臨床眼科67巻4号

2013年04月発行

特集 第66回日本臨床眼科学会講演集（2） 原著

HIV関連網膜微小血管症とHIV脳症との関連

著者： 岩﨑優子¹² 山本成径¹ 川口龍史¹² 尾碕憲子¹ 望月學² 味澤篤³ 村上喜三雄¹

所属機関： ¹がん・感染症センター都立駒込病院眼科 ²東京医科歯科大学大学院医歯学総合研究科眼科学分野 ³がん・感染症センター都立駒込病院感染症科

ページ範囲：P.453 - P.457

要約　目的：HIV関連網膜微小血管症とHIV脳症の関連について検討する。対象と方法：2000～2009年の間に都立駒込病院において抗HIV治療の開始時に眼科を受診した383例を対象とし，HIV関連網膜微小血管症の有無とHIV脳症の有無を後方視的に調査し，2つの疾患の関連を検討した。結果：HIV関連網膜微小血管症は85例，HIV脳症は9例でみられた。2つの疾患の間には有意な関連があった（p＝0.0013，Fisherの正確確率検定）。結論：HIV関連網膜微小血管症が存在する症例ではHIV脳症の合併頻度が高い。HIV関連網膜微小血管症は，HIV脳症合併の危険因子である可能性がある。

参考文献

1）Holland GN, Pepose JS, Pettit TH et al：Acquired immune deficiency syndrome：Ocular manifestations. Ophthalmology　90：859-873, 1983

2）Lai TY, Wong RL, Luk FO et al：Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era. Clin Experiment Ophthamol　39：99-104, 2011

3）Mansour AM, Jampol LM, Logani S et al：Cotton-wool spots in acquired immunodeficiency syndrome compared with diabetes mellitus, systemic hypertension, and central retinal vein occlusion. Arch Ophthalmol　106：1074-1077, 1988

4）Jabs DA, Quinn TC：Acquired immunodeficiency syndrome. In：Pepose JS, Holland GN, Wilhelmus KR：Ocular Infection and Immunity. 1st ed. 289-310, Mosby-Year Book, St Louis, 1996

5）Spaide RF, Gaissinger A, Podhorzer JR：Risk factors for cotton-wool spots and for cytomegalovirus retinitis in patients with human immunodeficiency virus infection. Ophthalmology　102：1860-1864, 1995

6）Furrer H, Barloggio A, Egger M et al：Swiss HIV Cohort Study：Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma. Ophthalmology　110：432-436, 2003

7）Dadgostar H, Holland GN, Huang X et al：Hemorheologic abnormalities associated with HIV infection：in vivo assessment of retinal microvascular blood flow. Invest Ophthalmol Vis Sci　47：3933-3938, 2006

8）Engstrom RE Jr, Holland GN, Hardy WD et al：Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol　109：153-161, 1990

9）Tozzi V, Balestra P, Galgani S et al：Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS　13：1889-1897, 1999

10）Bhaskaran K, Mussini C, Antinori A et al：CASCADE Collaboration：Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol　63：213-221, 2008

11）Sacktor N：The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol　8（Suppl 2）：115-121, 2002

12）Dore GJ, Correll PK, Li Y et al：Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS　13：1249-1253, 1999

13）Childs EA, Lyles RH, Selnes OA et al：Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology　52：607-613, 1999

14）Brew BJ, Pemberton L, Cunningham P et al：Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis　175：963-966, 1997

15）Wright EJ, Grund B, Robertson K et al：For the INSIGHT SMART Study Group：Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology　75：864-873, 2010

16）Geier SA, Schielke E, Tatsch K et al：Brain HMPAO-SPECT and ocular microangiopathic syndrome in HIV-1-infected patients. AIDS　7：1589-1594, 1993

17）Tucker KA, Robertson KR, Lin W et al：Neuroimaging in human immunodeficiency virus infection. J Neuroimmunol　157：153-162, 2004

18）Geier SA, Perro C, Klauss V et al：HIV-related ocular microangiopathic syndrome and cognitive functioning. J Acquir Immune Defic Syndr　6：252-258, 1993

19）Freeman WR, McCutchan JA, Arevalo JF et al：HNRC Group：The relationship between AIDS retinal cotton wool spots and neuropsychological impairment in HIV-positive individuals in the pre-highly active antiretroviral therapy era. Ocul Immunol Inflamm　12：25-33, 2004